Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...

The 10 most undervalued stocks from our Best Companies to Own list as of Feb. 27, 2025, were: Here’s a little bit about why ...

The founders of Bugworks Research are attempting to bring to market a new class of antibiotics--a first in almost half a ...

Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...

A report by drugs firm GSK - seen by the BBC - shows it learned ... of really quite dramatic changes that can occur," he says. A list of organisations in the UK offering support and information ...

Here are the critical medicines in short supply in the EU, according to the latest available information from the EMA and ...

Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...

Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that ...

"GSK's new drugs and development pipeline will be crucial ... and re GSK has joined a lengthening list of companies that have paused diversity, equity, and inclusion (DEI) targets under pressure ...

Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced its eighth annual Female Founders list, honoring HealthTree CEO and Founder ...

The strong US sales have come despite a list price of around $47,000 ... Regulators have started reviews of GSK's depemokimab, aiming to become the first drug for asthma that can be dosed twice ...